♟️ Thursday 6 August 2026 Thu, 6 Aug 2026

Iris Cairns Property Trust has waived all remaining conditions on its $3.87 per unit takeover bid for Reef Casino Trust, securing 80.97% ownership and setting a firm 14 August close date.

Challenger Gold has completed an A$85 million equity raise backed by key insiders and appointed a new leadership team to drive its transition from exploration to development at Hualilan and El Guayabo.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

Beach Energy (ASX:BPT) reported a 742% jump in net profit to $281 million for FY26 despite a 9% revenue decline, driven by Waitsia Gas Plant reaching full capacity and stringent cost control. The company declared a fully franked final dividend of 2 cents per share.

Aura Consolidated Group delivers strong pro forma Q2 2026 results with 27% revenue growth and a 51% improvement in adjusted EBITDA following its acquisition of Qoria.

Block, Inc. delivered a robust Q2 2026 with 25% gross profit growth, driven by strong Cash App and Square performances, and raised its full-year guidance reflecting accelerating AI integration and hardware innovation.

AMP Limited reported a robust first half of 2026, with statutory profit rising 57% to $154 million and underlying profit up 33%, driven by strong Platforms growth, positive cashflows, and a doubling of China partnership contributions.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Kinatico Limited reports a robust FY26 with SaaS revenue growth driving total revenue up 9.4% to $35.2 million and net profit after tax soaring 78.5% to $2.0 million, underpinned by its AI-native compliance platform.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.

Promisia Healthcare is set to acquire Chatswood Retirement Village in Christchurch for $25 million, bolstering its East Christchurch presence and promising immediate earnings accretion.